Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors

Autor: Pierre Dubus, Roco Sotillo, Mariano Barbacid, Javier Martn, Ernesto de la Cueva, Marcos Malumbres, Sagrario Ortega
Jazyk: angličtina
Rok vydání: 2001
Předmět:
Male
Time Factors
Lymphoma
Mutant
Cell Cycle Proteins
Mice
Tumor Suppressor Protein p14ARF
Hereditary Melanoma
Melanoma
Mice
Knockout

Recombination
Genetic

biology
Kinase
General Neuroscience
Cell Cycle
Homozygote
Teratoma
Sarcoma
3T3 Cells
Exons
Penetrance
Cyclin-Dependent Kinases
Gene Expression Regulation
Neoplastic

Female
Cyclin-Dependent Kinase Inhibitor p27
Blotting
Western

Molecular Sequence Data
General Biochemistry
Genetics and Molecular Biology

Article
Sex Factors
Transformation
Genetic

Cyclin-dependent kinase
Gene knockin
Proto-Oncogene Proteins
Animals
Humans
Point Mutation
Genetic Predisposition to Disease
Molecular Biology
Alleles
Cyclin-Dependent Kinase Inhibitor p16
General Immunology and Microbiology
Cyclin-dependent kinase 4
Point mutation
Tumor Suppressor Proteins
Cyclin-Dependent Kinase 4
Fibroblasts
Genes
p53

Molecular biology
Precipitin Tests
Genes
ras

Protein Biosynthesis
Mutation
biology.protein
Cancer research
Popis: We have introduced a point mutation in the first coding exon of the locus encoding the cyclin-dependent kinase 4 (Cdk4) by homologous recombination in embryonic stem cells. This mutation (replacement of Arg24 by Cys) was first found in patients with hereditary melanoma and renders Cdk4 insensitive to INK4 inhibitors. Here, we report that primary embryonic fibroblasts expressing the mutant Cdk4R24C kinase are immortal and susceptible to transformation by Ras oncogenes. Moreover, homozygous Cdk4(R24C/R24C) mutant mice develop multiple tumors with almost complete penetrance. The most common neoplasia (endocrine tumors and hemangiosarcomas) are similar to those found in pRb(+/-) and p53(-/-) mice. This Cdk4 mutation cooperates with p53 and p27(Kip1) deficiencies in decreasing tumor latency and favoring development of specific tumor types. These results provide experimental evidence for a central role of Cdk4 regulation in cancer and provide a valuable model for testing the potential anti-tumor effect of Cdk4 inhibitors in vivo.
Databáze: OpenAIRE